Works matching IS 20555822 AND DT 2025 AND VI 12 AND IP 2

Results: 82
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Atrial cardiomyopathy.

    Published in:
    ESC Heart Failure, 2025, v. 12, n. 2, p. 727, doi. 10.1002/ehf2.15158
    By:
    • Kosmala, Wojciech;
    • Przewłocka‐Kosmala, Monika
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study.

    Published in:
    ESC Heart Failure, 2025, v. 12, n. 2, p. 1336, doi. 10.1002/ehf2.15148
    By:
    • García‐García, Cosme;
    • López‐Sobrino, Teresa;
    • Sanz‐Girgas, Esther;
    • Cueto, Maria R.;
    • Aboal, Jaime;
    • Pastor, Pablo;
    • Buera, Irene;
    • Sionis, Alessandro;
    • Andrea, Rut;
    • Rodríguez‐López, Judit;
    • Sánchez‐Salado, Jose Carlos;
    • Tomas, Carlos;
    • Bañeras, Jordi;
    • Ariza, Albert;
    • Lupón, Josep;
    • Bayés‐Genís, Antoni;
    • Rueda, Ferran
    Publication type:
    Article
    23

    Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study.

    Published in:
    ESC Heart Failure, 2025, v. 12, n. 2, p. 1326, doi. 10.1002/ehf2.15147
    By:
    • Willixhofer, Robin;
    • Contini, Mauro;
    • Emdin, Michele;
    • Magrì, Damiano;
    • Bonomi, Alice;
    • Salvioni, Elisabetta;
    • Celeste, Fabrizio;
    • Del Torto, Alberico;
    • Passino, Claudio;
    • Capelle, Christophe D.J.;
    • Arzilli, Chiara;
    • Fiori, Emiliano;
    • Capra, Nicolò;
    • Kronberger, Christina;
    • Ermolaev, Nikita;
    • Kammerlander, Andreas;
    • Musumeci, Beatrice;
    • Vergaro, Giuseppe;
    • Castiglione, Vincenzo;
    • Rettl, René
    Publication type:
    Article
    24
    25

    Considerations for drug trials in hypertrophic cardiomyopathy.

    Published in:
    ESC Heart Failure, 2025, v. 12, n. 2, p. 1095, doi. 10.1002/ehf2.15138
    By:
    • Farrant, John P.;
    • Schmitt, Matthias;
    • Reid, Anna B.;
    • Garratt, Clifford J.;
    • Newman, William G.;
    • Malhotra, Aneil;
    • Beynon, Rhys;
    • Mahmod, Masliza;
    • Raman, Betty;
    • Cooper, Robert M.;
    • Dawson, Dana;
    • Green, Thomas;
    • Prasad, Sanjay K.;
    • Singh, Anvesha;
    • Dodd, Susanna;
    • Watkins, Hugh;
    • Neubauer, Stefan;
    • Miller, Christopher A.
    Publication type:
    Article
    26
    27
    28

    Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator.

    Published in:
    ESC Heart Failure, 2025, v. 12, n. 2, p. 1295, doi. 10.1002/ehf2.15141
    By:
    • Abumayyaleh, Mohammad;
    • Koepsel, Katharina;
    • Erath, Julia W.;
    • Kuntz, Thomas;
    • Klein, Norbert;
    • Kovacs, Boldizsar;
    • Duru, Firat;
    • Saguner, Ardan M.;
    • Blockhaus, Christian;
    • Shin, Dong‐In;
    • Kreimer, Fabienne;
    • Gotzmann, Michael;
    • Lapp, Hendrik;
    • Beiert, Thomas;
    • Aweimer, Assem;
    • Mügge, Andreas;
    • Weiß, Christel;
    • El‐Battrawy, Ibrahim;
    • Akin, Ibrahim
    Publication type:
    Article
    29
    30

    Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats.

    Published in:
    ESC Heart Failure, 2025, v. 12, n. 2, p. 1304, doi. 10.1002/ehf2.15145
    By:
    • Nordén, Einar Sjaastad;
    • Bendiksen, Bård Andre;
    • Bergo, Kaja Knudsen;
    • Espe, Emil Knut Stenersen;
    • McGinley, Gary;
    • Hasic, Almira;
    • Hauge‐Iversen, Ida Marie;
    • Ugland, Hege Katrin;
    • Shen, Xin;
    • Frisk, Michael;
    • Mabotuwana, Nishani S.;
    • Louch, William E.;
    • Hussain, Rizwan I.;
    • Zhang, Lili;
    • Sjaastad, Ivar;
    • Cataliotti, Alessandro;
    • Christensen, Geir
    Publication type:
    Article
    31
    32

    Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life.

    Published in:
    ESC Heart Failure, 2025, v. 12, n. 2, p. 1271, doi. 10.1002/ehf2.15136
    By:
    • Liao, Jia;
    • Chen, Yang;
    • Ling, Zhiyu;
    • Pürerfellner, Helmut;
    • Martinek, Martin;
    • Derndorfer, Michael;
    • Niel, Johannes;
    • Ebrahimi, Ramin;
    • Heukäufer, Matthias;
    • Janschel, Sarah;
    • Di Vece, Davide;
    • Empen, Klaus;
    • Hummel, Astrid;
    • Chamling, Bishwas;
    • Futyma, Piotr;
    • Ebrahimi, Fahim;
    • Kiuchi, Márcio G.;
    • Liu, Shaowen;
    • Yin, Yuehui;
    • Schratter, Alexandra
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40

    eGFR slope as predictor of mortality in heart failure patients.

    Published in:
    ESC Heart Failure, 2025, v. 12, n. 2, p. 1217, doi. 10.1002/ehf2.15128
    By:
    • Verstreken, Sofie;
    • Beles, Monika;
    • Oeste, Clara L.;
    • Moya, Ana;
    • Masuy, Imke;
    • Dierckx, Riet;
    • Heggermont, Ward;
    • Dauw, Jeroen;
    • Hens, Dries;
    • Bartunek, Jozef;
    • Vanderheyden, Marc
    Publication type:
    Article
    41

    Phenotyping patients with chronic obstructive pulmonary disease and heart failure.

    Published in:
    ESC Heart Failure, 2025, v. 12, n. 2, p. 900, doi. 10.1002/ehf2.15127
    By:
    • Becher, Peter Moritz;
    • Lindberg, Felix;
    • Benson, Lina;
    • Hage, Camilla;
    • Dahlström, Ulf;
    • Rosenkranz, Stephan;
    • Cosentino, Francesco;
    • Rosano, Giuseppe M.C.;
    • Blankenberg, Stefan;
    • Kirchhof, Paulus;
    • Braunschweig, Frieder;
    • Lund, Lars H.;
    • Savarese, Gianluigi
    Publication type:
    Article
    42

    Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study.

    Published in:
    ESC Heart Failure, 2025, v. 12, n. 2, p. 1203, doi. 10.1002/ehf2.15126
    By:
    • Nies, Richard J.;
    • Ney, Svenja;
    • Kindermann, Ingrid;
    • Bewarder, Yvonne;
    • Zimmer, Angela;
    • Knebel, Fabian;
    • Hahn, Katrin;
    • Spethmann, Sebastian;
    • Luedike, Peter;
    • Michel, Lars;
    • Rassaf, Tienush;
    • Papathanasiou, Maria;
    • Störk, Stefan;
    • Cejka, Vladimir;
    • Polzin, Amin;
    • Voss, Fabian;
    • Kelm, Malte;
    • Unsöld, Bernhard;
    • Meindl, Christine;
    • Paulus, Michael
    Publication type:
    Article
    43
    44

    Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial.

    Published in:
    ESC Heart Failure, 2025, v. 12, n. 2, p. 1455, doi. 10.1002/ehf2.15124
    By:
    • Roncalli, Jerome;
    • Roubille, François;
    • Meyer, Nicolas;
    • Pompilio, Giulio;
    • Leroux, Lionel;
    • Henon, Philippe;
    • Trebuchet, Guillaume;
    • Criquet, Anthony;
    • de Kalbermatten, Matthieu;
    • Saloux, Eric;
    • Manrique, Alain;
    • Marie, Pierre‐Yves;
    • Bhatt, Deepak L.;
    • Solomon, Scott D.;
    • Montalescot, Gilles;
    • Newby, David E.;
    • Zannad, Faiez
    Publication type:
    Article
    45
    46
    47
    48
    49
    50